Marker Therapeutics Inc
Biotechnology
Healthcare
MRKR
11.11 M shares
NASDAQ US
traded
01 Aug 2025
listed
no
open
1.40
52 week high
5.96
high
1.40
52 week low
0.00
previous Close
1.40
P/E ratio
market cap
16.52 M
div yield
0
net incoming
-4.45 M
-15.84 %
net profit margin
-1273.55 %
-1103.00 %
operating incoming
-4.61 M
-19.37 %
net change in cash
-5.50 M
-153.95 %
cash on hand
13.69 M
-28.65 %
top